News Enzymatica AB

Equities

ENZY

SE0003943620

Delayed Nasdaq Stockholm Other stock markets 08:19:31 16/05/2024 pm IST			5-day change	1st Jan Change
3.2 ^SEK	0.00%		+1.91%	-18.88%

25/04	Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
27/03	Enzymatica AB Announces Composition of Nomination Committee	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bulletin from annual general meeting of Enzymatica AB (publ) on May 7, 2024	07/05	AQ
BioStock: MDR certification was Enzymatica's highlight in Q1	29/04	AQ
Enzymatica Q1 - Continued growth in own markets, but a lack of partner orders	26/04	AQ
Interim report Q1/2024: MDR certification opens up great commercial opportunities	25/04	AQ
Enzymatica AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Enzymatica publishes annual report for 2023	09/04	AQ
Notice of Annual General Meeting 2024 in Enzymatica AB (publ)	28/03	AQ
Enzymatica AB Announces Composition of Nomination Committee	28/03	CI
BioStock: Enzymatica comments on MDR certification for ColdZyme	20/03	AQ
Enzymatica announces outcome of new rights issue	15/03	AQ
Enzymatica Obtains CE Marking for ColdZyme Mouth Spray	11/03	MT
ColdZyme® certified under the new EU medical device regulation (MDR)	11/03	AQ
BioStock: Enzymatica's partners await MDR certification and study results	26/02	AQ
Enzymatica publishes information memorandum about rights issue of shares	19/02	AQ
Enzymatica Q4 - Important year ahead and an expected rights issue	19/02	AQ
Enzymatica's rights issue is secured to 100 percent	16/02	AQ
Year-end report 2023: Scientific and regulatory progress generating international interest	16/02	AQ
Enzymatica AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02	CI
Enzymatica's Board of Directors decides on a new rights issue of SEK 27.4 million	16/02	AQ
Enzymatica's Chairman to BioStock: "Our new research data makes 2024 an exciting year"	21/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Enzymatica AB

Equities

ENZY

SE0003943620

Summary

Filters